1. |
Sultana A, Smith CT, Cunningham D, et al. Meta, analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Br J Cancer, 2008, 99(1): 6-13.
|
2. |
Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clini, 2015, 65(6): 457-480.
|
3. |
Abue M, Yokoyama M, Shibuya R, et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. Int J Oncol, 2015, 46(2): 539-547.
|
4. |
Satake F K, Kanazawa G, Kho I, et al. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma. J Surg Oncol, 1985, 29(1): 15-21.
|
5. |
Ambros V. The functions of animal microRNAs. Nature, 2004, 431(7006): 350-355.
|
6. |
Haug U, Wente MN, Seiler CM, et al. Stool testing for the early detection of pancreatic cancer: rationale and current evidence. Expert Rev Mol Diagn, 2008, 8(6): 753-759.
|
7. |
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Pro Natl Acad Sci USA, 2002, 99(24): 15524-15529.
|
8. |
Navon R, Wang H, Steinfeld I, et al. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. Plos One, 2009, 4(11): e8003.
|
9. |
Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem, 2010, 56(11): 1733-1741.
|
10. |
Zhao H, Shen J, Medico L, et al. A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer. Plos One, 2010, 5(10): e13735.
|
11. |
邬兰, 张永, 曾宪涛. QUADAS-2 在诊断准确性研究的质量评价工具中的应用. 湖北医药学院学报, 2013, (3): 201-208.
|
12. |
Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007, 120(5): 1046-1054.
|
13. |
Dillhoff M, Liu J, Frankel W, et al. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg, 2008, 12(12): 2171-2176.
|
14. |
Habbe N, Koorstra JB, Mendell JT, et al. MicroRNA miR, 155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 2009, 8(4): 340-346.
|
15. |
Wang J, Chen J, Chang P, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood, based biomarkers of disease. Cancer Prev Res (Phila), 2009, 2(9): 807-813.
|
16. |
Hanoun N, Delpu Y, Suriawinata AA, et al. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem, 2010, 56(7): 1107-1118.
|
17. |
Morimura R, Komatsu S, Ichikawa D, et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer, 2011, 22, 105(11): 1733-1740.
|
18. |
Ryu JK, Matthaei H, Dal Molin, et al. Elevated microRNA miR-21 Levels in Pancreatic Cyst Fluid Are Predictive of Mucinous Precursor Lesions of Ductal Adenocarcinoma. Pancreatology, 2011, 11(3): 343-350.
|
19. |
Szafranska-Schwarzbach AE, Whitcomb DC, Lloyd MB, et al. A Multi-center Study of a MicroRNA-based Assay for the Diagnosis of Pancreatic Ductal Adenocarcinoma in Fine Needle Aspirates. Pancreas, 2011, 40(8): 1356-1356.
|
20. |
刘建强, 高军, 李兆申, 等. 胰腺癌患者血浆 miR-155 检测及其诊断价值. 中华胰腺病杂志, 2011, 11(2): 79-81.
|
21. |
刘建强, 高军, 任艳, 等. 血浆 miR-21 对胰腺癌的诊断价值. 世界华人消化杂志, 2011, (8): 860-863.
|
22. |
任艳, 高军, 王小玮, 等. 粪便 microRNAs 检测用于胰腺癌筛查诊断的价值评价. 中华胰腺病杂志, 2011, 11(2): 104-106.
|
23. |
Bauer AS, Keller A, Costello E, et al. Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue. Plos One, 2012, 7(4): e34151.
|
24. |
Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer, 2012, 131(3): 683-691.
|
25. |
Liu R, Chen X, Du Y, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem, 2012, 58(3): 610-618.
|
26. |
Munding JB, Adai AT, Maghnouj A, et al. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer, 2012, 131(2): E86-95.
|
27. |
Panarelli NC, Chen YT, Zhou XK, et al. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma. Pancreas, 2012, 41(5): 685-690.
|
28. |
Ren Y, Gao J, Liu JQ, et al. Differential signature of fecal microRNAs in patients with pancreatic cancer. Mol Med Rep, 2012, 6(1): 201-209.
|
29. |
Schultz NA, Werner J, Willenbrock H, et al. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol, 2012, 25(12): 1609-1622.
|
30. |
潘峰, 闻洋, 马士杰, 等. 血浆 miRNA 表达谱与胰腺癌相关性的研究. 南京医科大学学报(自然科学版), 2012, (11): 1541-1544.
|
31. |
Li A, Yu J, Kim H, et al. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res, 2013, 19(13): 3600-3610.
|
32. |
Wang WS, Liu LX, Li GP, et al. Combined serum CA19-9 and miR-27a, 3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev Res (Phila), 2013, 6(4): 331-338.
|
33. |
Zhao C, Zhang J, Zhang S, et al. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Oncol Rep, 2013, 30(1): 276-284.
|
34. |
丁国平. 胰腺癌 exosomal microRNA 及其对 DC 免疫功能的影响. 杭州: 浙江大学, 2013.
|
35. |
Madhavan B, Yue S, Galli U, et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int J Cancer, 2015, 136(11): 2616-2627.
|
36. |
Ganepola GA, Rutledge JR, Suman P, et al. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. World J Gastrointest Oncol, 2014, 15, 6(1): 22-33.
|
37. |
Cote GA, Gore AJ, Mcelyea SD, et al. A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Am J Gastroenterol, 2014, 109(12): 1942-1952.
|
38. |
Lin MS, Chen WC, Huang JX, et al. Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer. Int J Clin Exp Med, 2014, 7(12): 5226-5234.
|
39. |
Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer. JAMA, 2014, 311(4): 392-404.
|
40. |
Yang JY, Sun YW, Liu DJ, et al. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Am J Cancer Res, 2014, 4(6): 663-673.
|
41. |
Zhang J, Zhao CY, Zhang SH, et al. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma. Oncol Rep, 2014, 31(3): 1157-1164.
|
42. |
潘文征. 与胰腺癌诊断相关血浆 miRNA 的研究. 济南: 山东大学, 2014.
|
43. |
石围. miR-155、miR-196a 异常表达在胰腺癌诊断中的研究. 昆明: 昆明医科大学, 2014.
|
44. |
杨建宇, 孙勇伟, 花荣. 粪便 miRNAs 在胰腺导管腺癌筛查诊断中的应用价值. 肝胆胰外科杂志, 2014, 26(5): 388-392.
|
45. |
Komatsu S, Ichikawa D, Miyamae M, et al. Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma. Expert Opin Biol Ther, 2015, 15(6): 773-785.
|
46. |
Permuth-wey J, Chen DT, Fulp WJ, et al. Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas. Cancer Prev Res (Phila), 2015, 8(9): 826-834.
|
47. |
胡应霞, 张海蓉, 石围, 等. 血浆 miR-210 联合血清肿瘤标志物对胰腺癌的诊断价值. 世界华人消化杂志, 2015, (1): 147-152.
|
48. |
汪善兵, 刘佳培, 雷开键, 等. 胰腺癌患者血浆中 miRNAs 异常高表达与临床特征相关性的研究. 肿瘤, 2015, (8): 905-910.
|
49. |
王晓刚, 童钟, 金钢. 血清 miR-155 对胰腺癌诊断和预后评估的价值. 中华肝胆外科杂志, 2015, 21(3): 189-193.
|
50. |
吴阳, 王佐正, 黄李雅. 血清 miRNAs 作为胰腺癌诊断肿瘤标志物的初步研究. 宁夏医学杂志, 2015, 37(8): 675-677.
|
51. |
Jemal A, Siegel R, Xu J, et al. Cancer statistics. Ca Cancer J Clin, 2010, 60(5): 277-300.
|
52. |
陈万青, 张思维, 曾红梅, 等. 中国 2010 年恶性肿瘤发病与死亡. 中国肿瘤, 2014, 23(1): 1-10.
|
53. |
Real FX. A “catastrophic hypothesis” for pancreas cancer progression. Gastroenterology, 2003, 124(7): 1958-1964.
|
54. |
曾宪涛, 何明武. 诊断准确性试验 Meta 分析软件一本通. 军事医学科学出版社, 2014.
|
55. |
Ding Z, Wu H, Zhang J, et al. MicroRNAs as novel biomarkers for pancreatic cancer diagnosis: a meta-analysis based on 18 articles. Tumour Biol, 2014, 35(9): 8837-8848.
|
56. |
Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008, 18(10): 997-1006.
|